机译:发现新型螺吲哚衍生物作为选择性的坦克酶抑制剂
RIKEN Ctr Sustainable Resource Sci Drug Discovery Chem Platform Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
Meiji Seika Pharma Co Ltd Med Chem Lab Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
RIKEN Ctr Sustainable Resource Sci Chem Genom Res Grp 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Computat Chem Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Struct Biol Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Struct Biol Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
Meiji Seika Pharma Co Ltd Pharmacokinet &
Anal Lab Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Chem Platform Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Chem Platform Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Chem Platform Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Seed Cpds Exploratory Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Seed Cpds Exploratory Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Chem Genom Res Grp 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Chem Genom Res Grp 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Program Drug Discovery &
Med Technol Platforms 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Computat Chem Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Computat Chem Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Struct Biol Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
RIKEN Ctr Biosyst Dynam Res Drug Discovery Struct Biol Platform Unit Tsurumi Ku 1-7-22 Suehiro Cho Yokohama Kanagawa 2300045 Japan;
Meiji Seika Pharma Co Ltd Mfg &
Control Res Labs Proc Chem Lab Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
Meiji Seika Pharma Co Ltd Med Chem Lab Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
Meiji Seika Pharma Co Ltd Med Chem Lab Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
Meiji Seika Pharma Co Ltd Pharmacol Res Lab Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
Meiji Seika Pharma Co Ltd Pharmaceut Res Ctr Div Pharmaceut Res Kohoku Ku 760 Morooka Cho Yokohama Kanagawa 2228567 Japan;
Japanese Fdn Canc Res Ctr Canc Chemotherapy Div Mol Biotherapy Koto Ku 3-8-31 Ariake Tokyo 1358850 Japan;
Japanese Fdn Canc Res Ctr Canc Chemotherapy Div Mol Biotherapy Koto Ku 3-8-31 Ariake Tokyo 1358850 Japan;
Japanese Fdn Canc Res Ctr Canc Chemotherapy Div Mol Biotherapy Koto Ku 3-8-31 Ariake Tokyo 1358850 Japan;
Japanese Fdn Canc Res Ctr Canc Chemotherapy Div Mol Biotherapy Koto Ku 3-8-31 Ariake Tokyo 1358850 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Seed Cpds Exploratory Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
RIKEN Ctr Sustainable Resource Sci Drug Discovery Chem Platform Unit 2-1 Hirosawa Wako Saitama 3510198 Japan;
机译:发现新型螺吲哚衍生物作为选择性的坦克酶抑制剂
机译:发现高度选择性的不含水汽酶抑制剂,显示出对多种肿瘤衍生细胞系的生长抑制作用
机译:发现有效和选择性的非平面tankyrase抑制烟酰胺模拟物
机译:新的7-Oxycoumarin衍生物作为有效和选择性单胺氧化酶氧化酶的定量结构活性关系
机译:第一部分。具有吲哚胺2,3-二加氧酶抑制剂潜在活性的旋光色氨酸衍生物的合成:一种通过不对称催化氢化的方法。第二部分。含α1的GABA(A)/苯并二氮杂receptor受体亚型的选择性配体的设计,合成和药理作用:位于-3和-6位的β-咔啉及其相应的二价配体的SAR研究。第三部分。重要生物遗传中间体,(+)-聚神经氨酸和(+)-聚神经氨酸醛,以及16-表-维西辛和Macusine A的首次对映体全合成。
机译:发现一种新型三唑吡啶衍生物作为油脂酶抑制剂
机译:设计和发现2-芳基喹唑啉-4-酮类化合物作为坦科酶的有效和选择性抑制剂